Advent Capital Management’s NEVRO CORP. NVRO Stock Holding History

Advent Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200	Closed	-$34K	–	339
2018 Q2	$34K	Buy	+200	New	+$16.6K	﹤0.01%	249

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Advent Capital Management's NVRO Position: Q1 2019 in Review

Advent Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 2,000 shares — an estimated $78K sold.

Advent Capital Management first reported a position in NVRO in Q1 2018 and held it in 3 quarters. The position peaked at $1.21M in Q1 2018. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

Advent Capital Management reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
Advent Capital Management sold 2,000 NEVRO CORP. shares in Q1 2019, an estimated $78K.
Advent Capital Management first reported a position in NEVRO CORP. in Q1 2018 and held it in 3 quarters.
Advent Capital Management's NEVRO CORP. position peaked at $1.21M in Q1 2018.
172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on Advent Capital Management's 13F filing for Q1 2019, filed 15 May 2019.